Amarin Corp Plc (AMRN)

[dukesking]

Thanks Sleven, I appreciate you’re response about the API and the information it contained. I’ll keep an eye on that site going forward.
I agree that the exclusivity agreements are protecting the majority of market share for Vascepa. Some scripts are also due to some payers honoring patents for CVD via PA’s and doctors using DAW. Let’s hope they continue to do so.
I’m not trying to panic anyone or create fear about Teva launching. I’m trying to keep the info out there so others can decide it’s impact while also sharing my concerns about it. One concern is that we don’t know the details, including the duration, of those exclusivity agreements or how many of the approximately 60k scripts are due to those agreements. We need to be aware of this and do our own due diligence on determining the risks and relevance of TEVA’s launch and the length and strength of those agreements. I think this is one of KM’s concerns too and he’s keeping a close eye on it. Thanks for all your input and valuable DD.